This month’s key dermatology observances and upcoming July 4th savings.
View in browser
LiVDerm Newsletter - A Dose of News

July 2026

Facebook
LinkedIn
X
Instagram
YouTube

🧠 July Clinical Challenge

Which ONE of the following statements is FALSE?

  1. Melasma can recur or worsen even after successful treatment if photoprotection is not consistently maintained.

  2. Post-inflammatory hyperpigmentation is associated with changes in melanocyte activity following cutaneous inflammation or injury.

  3. Visible light plays a minimal role in pigmentary disorders such as melasma.

Answer: C is FALSE

Emerging evidence suggests that visible light may contribute to the development and worsening of pigmentary disorders, including melasma. This is particularly relevant in patients with skin of color.

✨ July Awareness

July Awareness

With both UV Safety Month and Hyperpigmentation Awareness Month this July, it serves as a reminder that pigmentary disorders are multifactorial and often require a layered management approach.

Management extends beyond treatment alone and should include preventive strategies such as consistent photoprotection and patient education.

🎆 July 4th Sale

July 4th Sale

Fourth of July savings kicks off today.

Keep an eye on your inbox for exclusive savings and special offers available for a limited time only.

📚 Featured Digital Education Hub

Cutaneous Oncology Digital Education Hub

Are you looking to dive deeper into skin cancer prevention, diagnosis, and management? Explore our Cutaneous Oncology Digital Education Hub, featuring on-demand content including past SBS session slides, and clinical insights focused on improving outcomes in skin cancer care.

Explore the Cutaneous Oncology Hub

📄 Featured Blogs

Predictive, Proactive, and Personalized

Predictive, Proactive, and Personalized: Leveraging Genomics and AI in Dermatology

Treatment, Trends, and Misinformation

Treatment, Trends, and Misinformation: A Guide to Educating Patients

How Bemotrizinol’s Approval May Brighten the Future of Dermatology

How Bemotrizinol's Approval May Brighten the Future of Dermatology

📰 Recent Articles

Stronger Together: Hidradenitis Suppurativa Awareness Week

Skin Cancer Myths and Misinformation That Put Millions of Americans at Risk

FDA Expands Sunscreen Options for the First Time in 20 Years

Positive Results Announced for Veradermics' Oral VDPHL01 in Male Pattern Hair Loss Trial

📲 Let's Connect

Stay inspired and in the know-connect with us for the latest updates, expert tips, and exclusive offers!

Facebook
LinkedIn
X / Twitter
Instagram
YouTube

This is an educational message from LiVDerm.
1801 N. Military Trail, Suite 110  •  Boca Raton, FL 33431, United States  •  561-893-8625
You are subscribed to this newsletter with the email address %user_email%.
To unsubscribe click here.